Suppr超能文献

网络荟萃分析 8 种中药注射剂联合化疗治疗结直肠癌。

Network meta-analysis of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment.

机构信息

Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

Linyi Traditional Chinese Medicine Hospital, No.211 Jiefang Road, Lanshan, Linyi, Shandong, China.

出版信息

J Cancer Res Clin Oncol. 2023 Sep;149(12):9823-9838. doi: 10.1007/s00432-023-04892-y. Epub 2023 May 29.

Abstract

OBJECTIVE

This study conducted a network meta-analysis to comprehensively compare the efficacy and safety of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment.

METHODS

We searched relevant previous studies from databases including Pubmed, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Biomedical Literature Service System (SinMed), VIP, and Wanfang Database. The searched studies spanned from the inception of databases to December 2022. The included randomized controlled trials were screened; data were extracted; and bias risk was assessed. The network meta-analysis was performed using Revman 5.4 software, R software, and STATA software.

RESULTS

Fifty randomized controlled studies were included, including 8 types of traditional Chinese medicine injection. The results showed that Aidi injection [OR 1.65,95%CI (1.33,2.05)], compound Kushenshen injection [OR 2.72,95%CI (2.12,3.51)], Kangai injection [OR 2.16,95%CI (1.56,3.02)], and Shenqi Fuzheng injection [OR 1.97,95%CI (1.24,3.15)] combined with chemotherapy in colorectal cancer treatment had a significantly higher objective response rate (p < 0.05) than single chemotherapy, and compound Kushen injection + chemotherapy [OR 2.72,95%CI (2.12,3.51)] regimen ranked the highest. The disease control rate of Aidi injection, Brucea javanica oil emulsion injection [OR 4.1,95%CI (1.74,10.43)], compound Kushen injection [OR 2.43,95%CI (1.73,3.44), Kangai injection[OR 2.31,95%CI  (1.51,3.58)], Kanglaite injection[OR 3.18,95%CI (1.52,6.9)], and Shenqi Fuzheng injection[OR 2.6,95%CI  (1.22,5.92)] combined with chemotherapy in the treatment of colorectal cancer was significantly improved (p < 0.05), and Brucea javanica oil emulsion injection + chemotherapy[OR 4.1,95%CI  (1.74,10.43)] regimen ranked the highest. The incidence of leukopenia reduction in the treatment of colorectal cancer was significantly reduced by Aidi injection[OR 0.32,95%CI  (0.24,0.43)], Brucea javanica oil emulsion injection [OR 0.34,95%CI  (0.17,0.68)] compound Kushen injection [OR 0.27,95%CI  (0.17,0.40)], Kangai injection [OR 0.23,95%CI  (0.14,0.37)], and Kanglaite injection [OR 0.20,95%CI  (0.09,0.45)] combined with chemotherapy (p < 0.05), and Kanglaite injection + chemotherapy [OR 0.20,95%CI  (0.09,0.45)] regimen ranked the highest. Aidi injection [OR 0.48,95%CI  (0.3,0.74)], Brucea javanica oil emulsion injection [OR 0.09,95%CI  (0.01,0.43)], and Kangai injection [OR 0.47,95%CI  (0.22,0.96)] combined with chemotherapy in the treatment of colorectal cancer significantly reduced the incidence of thrombocytopenia reduction (p < 0.05), and Brucea javanica oil emulsion injection + chemotherapy [OR 0.09,95%CI  (0.01,0.43)] regimen ranked the highest. Aidi injection [OR 0.49,95%CI  (0.32, 0.74)], Kangai injection [OR 0.26,95%CI (0.09,0.71)] combined with chemotherapy in the treatment of colorectal cancer significantly reduced the incidence of hemoglobin reduction (p < 0.05), and Kangai injection + chemotherapy [OR  0.26,95%CI  (0.09,0.71)] regimen ranked the highest. Aidi injection [OR 0.38,95%CI  (0.28,0.52)], compound Kushen injection [OR 0.23,95%CI  (0.15,0.36)] and Kangai injection [OR 0.19,95%CI  (0.12,0.30)] combined with chemotherapy in the treatment of colorectal cancer significantly reduced the incidence of nausea and vomiting (p < 0.05), and Kangai injection + chemotherapy[OR 0.19,95%CI  (0.12,0.30)] regimen ranked the highest. Aidi injection [OR 0.51,95%CI  (0.35,0.74)], compound Kushenshen injection [OR 0.27,95%CI  (0.15,0.47)], and Kanglaite injection [OR 0.31,95%CI  (0.13,0.69)] combined with chemotherapy in the treatment of colorectal cancer significantly reduced the incidence of abdominal pain and diarrhea (p < 0.05), and compound Kushen injection + chemotherapy [OR  0.27,95%CI  (0.15,0.47)] regimen ranked the highest.

CONCLUSION

Aidi injection, Brucea javanica oil emulsion injection, compound Kushen injection, Kangai injection, Shenqi Fuzheng injection, Kanglaite injection, Shenfu injection, and Xiaoaiping injection combined with chemotherapy functioned more effectively than single chemotherapy did in colorectal cancer treatment. Nevertheless, limited by the treatment quality and methodology of different intervention measures included in the study, this conclusion is expected to be scrutinized in higher-quality and rigorously designed randomized controlled trials. PROSPERO registration No.: CRD42023392398.

摘要

目的

本研究通过网状荟萃分析全面比较 8 种中药注射剂联合化疗治疗结直肠癌的疗效和安全性。

方法

我们检索了 PubMed、Embase、Web of Science、Cochrane 图书馆、中国知网(CNKI)、中国生物医学文献服务系统(SinMed)、维普及万方数据库,检索时间从数据库建立到 2022 年 12 月。筛选纳入的随机对照试验,提取数据,并评估偏倚风险。使用 Revman 5.4 软件、R 软件和 STATA 软件进行网状荟萃分析。

结果

共纳入 50 项随机对照研究,涉及 8 种中药注射剂。结果显示,艾迪注射液[OR 1.65,95%CI(1.33,2.05)]、复方苦参注射液[OR 2.72,95%CI(2.12,3.51)]、康艾注射液[OR 2.16,95%CI(1.56,3.02)]和参芪扶正注射液[OR 1.97,95%CI(1.24,3.15)]联合化疗治疗结直肠癌的客观缓解率明显高于单纯化疗,复方苦参注射液+化疗[OR 2.72,95%CI(2.12,3.51)]方案排名最高。艾迪注射液[OR 4.1,95%CI(1.74,10.43)]、鸦胆子油乳注射液[OR 0.34,95%CI(0.17,0.68)]、复方苦参注射液[OR 0.27,95%CI(0.17,0.40)]、康艾注射液[OR 0.23,95%CI(0.14,0.37)]、康莱特注射液[OR 0.38,95%CI(0.28,0.52)]和参芪扶正注射液[OR 0.26,95%CI(0.19,0.36)]联合化疗治疗结直肠癌的疾病控制率明显提高(p<0.05),鸦胆子油乳注射液+化疗[OR 4.1,95%CI(1.74,10.43)]方案排名最高。艾迪注射液[OR 0.32,95%CI(0.24,0.43)]、鸦胆子油乳注射液[OR 0.34,95%CI(0.17,0.68)]、复方苦参注射液[OR 0.27,95%CI(0.17,0.40)]、康艾注射液[OR 0.23,95%CI(0.14,0.37)]和康莱特注射液[OR 0.20,95%CI(0.09,0.45)]联合化疗降低结直肠癌白细胞减少症发生率(p<0.05),康莱特注射液+化疗[OR 0.20,95%CI(0.09,0.45)]方案排名最高。艾迪注射液[OR 0.48,95%CI(0.3,0.74)]、鸦胆子油乳注射液[OR 0.09,95%CI(0.01,0.43)]和康艾注射液[OR 0.47,95%CI(0.22,0.96)]联合化疗降低结直肠癌血小板减少症发生率(p<0.05),鸦胆子油乳注射液+化疗[OR 0.09,95%CI(0.01,0.43)]方案排名最高。艾迪注射液[OR 0.49,95%CI(0.32,0.74)]、康艾注射液[OR 0.26,95%CI(0.09,0.71)]联合化疗降低结直肠癌血红蛋白减少症发生率(p<0.05),康艾注射液+化疗[OR 0.26,95%CI(0.09,0.71)]方案排名最高。艾迪注射液[OR 0.38,95%CI(0.28,0.52)]、复方苦参注射液[OR 0.23,95%CI(0.15,0.36)]和康艾注射液[OR 0.19,95%CI(0.12,0.30)]联合化疗降低结直肠癌恶心呕吐发生率(p<0.05),康艾注射液+化疗[OR 0.19,95%CI(0.12,0.30)]方案排名最高。艾迪注射液[OR 0.51,95%CI(0.35,0.74)]、复方苦参注射液[OR 0.27,95%CI(0.15,0.47)]和康莱特注射液[OR 0.31,95%CI(0.13,0.69)]联合化疗降低结直肠癌腹痛腹泻发生率(p<0.05),复方苦参注射液+化疗[OR 0.27,95%CI(0.15,0.47)]方案排名最高。

结论

艾迪注射液、鸦胆子油乳注射液、复方苦参注射液、康艾注射液、参芪扶正注射液、康莱特注射液、参附注射液和消癌平注射液联合化疗在结直肠癌治疗中的疗效优于单纯化疗。然而,由于纳入研究中不同干预措施的治疗质量和方法学存在差异,该结论预计在更高质量和设计严谨的随机对照试验中需要进一步验证。PROSPERO 注册号:CRD42023392398。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验